论文信息 - Radioimmunotherapy with 90Y-ibritumomab tiuxetan is a safe and efficient treatment for patients with B-cell lymphoma relapsed after auto-SCT: an analysis of the international RIT-Network - 字舞流文

Radioimmunotherapy with 90Y-ibritumomab tiuxetan is a safe and efficient treatment for patients with B-cell lymphoma relapsed after auto-SCT: an analysis of the international RIT-Network

P. Zinzani | P. Zinzani | G. Wulf | K. Hohloch | L. Truemper | W. Linkesch | W. Jurczak | A. Deptała | M. Lorsbach | C. Windemuth-Kiesselbach | L. Truemper | Werner Linkesch | Karin Hohloch | Wojciech Jurczak | Andrzej Deptała | Gerald Wulf